Corporate News Update – Beijing Strong Biotechnologies Inc.
Beijing Strong Biotechnologies Inc. (ticker 300406.SZ) closed the trading session of Wednesday, 21 October 2026, unchanged at 0 % in the 24‑hour period that ended at 04:51 PM Central Europe. At the close, one share was available on the Shenzhen Stock Exchange for approximately CNY 12, a price that sits near the simple moving average of the last 200 trading days (CNY 11.64).
The company’s market capitalization currently stands at CNY 7 billion, with a total share supply of 586.1 million. Over the last 24 hours, roughly CNY 90 million of Beijing Strong Biotechnologies shares exchanged hands. Since the close of last month, the stock has risen 2.05 %, reflecting a modest but steady upward trend. In a broader context, the highest price the share has achieved in the past 52 weeks was CNY 16.05 (recorded 13 January 2026), while the 52‑week low was CNY 10.52 (recorded 29 June 2026).
Recent Corporate Development
On 20 October 2026, Beijing Strong Biotechnologies announced the acquisition of a newly granted invention patent titled “Method and Device for Detecting the Pre‑Band Phenomenon in Samples Pending Detection.” The patent, awarded by the State Intellectual Property Office, is intended to underpin the firm’s ongoing technology development and to strengthen its intellectual‑property portfolio. Management has indicated that, while the patent represents an important addition to the company’s technical assets, it is not expected to materially affect day‑to‑day operations. The announcement underscores the company’s commitment to maintaining a continuous innovation cycle and to reinforcing core competitiveness through new technical achievements.
Peer Performance Snapshot
The following table summarizes how related stocks have behaved over the past 24 hours:
| Company | Ticker | 24‑Hour Change | Current Price | Market Capitalisation | Additional Notes |
|---|---|---|---|---|---|
| Xinyu Iron & Steel | 600782.SS | 0 % | CNY 2.63 | CNY 8.4 bn | – |
| Shanghai Able Digital Science | 2687.HK | +0.2 % | HKD 138 | HKD 9.9 bn | P/E: 160.41 |
| Camel Group | 601311.SS | 0 % | CNY 7.12 | CNY 8.4 bn | P/E: 14.22; Q3 2026 briefing scheduled 21 Oct 2026 |
| Sino Prima Gas | 300483.SZ | 0 % | CNY 21.4 | CNY 8.4 bn | P/E: 20.22 |
| Oriental Energy | 002221.SZ | 0 % | CNY 5.3 | CNY 8.4 bn | – |
Company Profile
Beijing Strong Biotechnologies Inc. is a China‑based health‑care biotechnology firm founded in 2001 and headquartered in Beijing. The company specializes in in‑vitro diagnostics products and services, supplying a broad portfolio that includes clinical biochemistry reagents, automatic biochemistry analyzers, coagulation systems, serology tools, blood‑type test cards, and automated blood‑grouping analyzers. Beijing Strong Biotechnologies is listed on the Shenzhen Stock Exchange and operates both domestically and internationally. Further information can be found on its website at www.bsbe.com.cn .